Wouter Plattel

19PUBLICATIONS
74CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHistorical, comparative and typological linguistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 08, 2026
A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

Hans C Lee, Wouter J Plattel, Simon J Harrison

|Feb 04, 2026
Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Floriske G Stedema, Mirian Brink, Francien Huisman

|Dec 18, 2025
Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients.

Yujie Zhong, Johanna Bult, Nick Veltmaat

|Jul 09, 2025
Treatment and outcome of breast implant-associated anaplastic large cell lymphoma: a population-based cohort study in the Netherlands.

Frederik O Meeuwes, Mirian Brink, Marjolein W M van der Poel

|Jun 20, 2025
Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin lymphoma.

Sophie A Teesink, Lydia Visser, Marcel Nijland

|Apr 03, 2025
High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial.

Gotti Manuel, Yana Stepanishyna, Tetiana Skrypets

Pageof 4

Frequent Collaborators

7 joint publications

Marcel Nijland

6 joint publications

Mirian Brink

5 joint publications

Joost S P Vermaat

4 joint publications

Pieternella J Lugtenburg